Product Information
BUMETANIDE 1 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1075 per EA under NDC 16571067801. Its NADAC has been published 80 times since Feb 12, 2025.
FDA first approved this application on Dec 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212019FDA Approved
12/12/2019
TE Code
AB
On Market Since
6/3/2024
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 1 MG TABLET has been published 80 times since Feb 12, 2025, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1075 per EA |
|---|---|
| All-time high | $0.1750 (May 14, 2025) |
| All-time low | $0.1075 (Aug 19, 2026) |
| 52-week high | $0.1447 |
| 52-week low | $0.1075 |
| Median price | $0.1385 |
| Average price | $0.1389 |
| Largest weekly change | +12.8% (Feb 19, 2025) |
| Weeks tracked | 80 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 1 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1075 per EA (NDC 16571067801), effective Aug 19, 2026.
How has the price of BUMETANIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 1 MG TABLET has declined 25.5%. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 1 MG TABLET?
Since Feb 12, 2025, the NADAC for BUMETANIDE 1 MG TABLET has ranged from a low of $0.1075 (Aug 19, 2026) to a high of $0.1750 (May 14, 2025), with a median of $0.1385 per EA.
Are there cheaper alternatives to BUMETANIDE 1 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUMETANIDE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUMETANIDE 1 MG TABLET?
BUMETANIDE 1 MG TABLET (NDC 16571067801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.